Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:1152-1158
doi: 10.1161/hq0701.092104
doi: 10.1161/hq0701.092104
© 2001 American Heart Association, Inc.
Vascular Biology |
Cell Cycle Protein Expression in Vascular Smooth Muscle Cells In Vitro and In Vivo Is Regulated Through Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin
From the Department of Medicine/Cardiology (R.C.B.-D., U.S., V.J.D.), Giessen University, Giessen, Germany; Cardiovascular Research (M.J.M., L.Z.), Brigham and Women’s Hospital/Harvard Medical School, Boston, Mass; Medizinische Hochschule (H.E.v.d.L.), Hannover, Germany; and Falk Cardiovascular Research Center (R.E.M.), Stanford University School of Medicine, Stanford, Calif.
Correspondence to Victor J. Dzau, MD, Brigham and Women’s Hospital, Cardiovascular Research, Thorn-13, 75 Francis St, Boston, MA 02115. E-mail vdzau{at}bics.bwh.harvard.edu
Abstract—Cell cycle progression represents a key event in vascular proliferative diseases, one that depends on an increased rate of protein synthesis. An increase in phosphatidylinositol 3-kinase (PI 3-kinase) activity is associated with vascular smooth muscle cell proliferation, and rapamycin, which blocks the activity of the mammalian target of rapamycin, inhibits this proliferation in vitro and in vivo. We hypothesized that these 2 molecules converge on a critical pathway of translational regulation that is essential for successful upregulation of cell cycle–regulatory proteins in activated smooth muscle cells. p70S6 kinase, a target of PI 3-kinase and the mammalian target of rapamycin, was rapidly activated on growth factor stimulation of quiescent coronary artery smooth muscle cells and after balloon injury of rat carotid arteries. The translational repressor protein 4E-binding protein 1 was similarly hyperphosphorylated under these conditions. These events were associated with increases in the protein levels of cyclin B1, cyclin D1, cyclin E, cyclin-dependent kinase 1, cyclin-dependent kinase 2, proliferating cell nuclear antigen, and p21Cip1 in vivo and in vitro, whereas inhibition of the PI 3-kinase signaling pathway with either rapamycin or wortmannin blocked the upregulation of these cell cycle proteins, but not mRNA, and arrested the cells in vitro before S phase. In contrast to findings in other cell types, growth factor– or balloon injury–induced downregulation of the cell cycle inhibitor p27Kip1 was not affected by rapamycin treatment. These data suggest that cell cycle progression in vascular cells in vitro and in vivo depends on the integrity of the PI 3-kinase signaling pathway in allowing posttranscriptional accumulation of cell cycle proteins.
Key Words: cell cycle protein • S6 kinase • phosphatidylinositol 3-kinase • balloon injury • vascular smooth muscle
This article has been cited by other articles:
 |
|
 |
|
  A. Ogawa, A. L. Firth, W. Yao, M. M. Madani, K. M. Kerr, W. R. Auger, S. W. Jamieson, P. A. Thistlethwaite, and J. X.-J. Yuan Inhibition of mTOR attenuates store-operated Ca2+ entry in cells from endarterectomized tissues of patients with chronic thromboembolic pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, October 1, 2009; 297(4): L666 - L676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Morello, A. Perino, and E. Hirsch Phosphoinositide 3-kinase signalling in the vascular system Cardiovasc Res, May 1, 2009; 82(2): 261 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ferri, A. Granata, C. Pirola, F. Torti, P. J. Pfister, R. Dorent, and A. Corsini Fluvastatin Synergistically Improves the Antiproliferative Effect of Everolimus on Rat Smooth Muscle Cells by Altering p27Kip1/Cyclin E Expression Mol. Pharmacol., July 1, 2008; 74(1): 144 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, Y. Bai, L. Qin, P. Zhang, T. Yi, S. A. Teesdale, L. Zhao, J. S. Pober, and G. Tellides Interferon-{gamma} Induces Human Vascular Smooth Muscle Cell Proliferation and Intimal Expansion by Phosphatidylinositol 3-Kinase Dependent Mammalian Target of Rapamycin Raptor Complex 1 Activation Circ. Res., September 14, 2007; 101(6): 560 - 569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. S. Santiago, H. Ishii, S. Shafi, R. Khurana, P. Kanellakis, R. Bhindi, M. J. Ramirez, A. Bobik, J. F. Martin, C. N. Chesterman, et al. Yin Yang-1 Inhibits Vascular Smooth Muscle Cell Growth and Intimal Thickening by Repressing p21WAF1/Cip1 Transcription and p21WAF1/Cip1-Cdk4-Cyclin D1 Assembly Circ. Res., July 20, 2007; 101(2): 146 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nakamura, S.-i. Yamagishi, T. Matsui, T. Yoshida, K. Takenaka, Y. Jinnouchi, Y. Yoshida, S.-i. Ueda, H. Adachi, and T. Imaizumi Pigment Epithelium-Derived Factor Inhibits Neointimal Hyperplasia after Vascular Injury by Blocking NADPH Oxidase-Mediated Reactive Oxygen Species Generation Am. J. Pathol., June 1, 2007; 170(6): 2159 - 2170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Larsson, D. M. Perlman, D. Fan, C. S. Reilly, M. Peterson, C. Dahlgren, Z. Liang, S. Li, V. A. Polunovsky, C. Wahlestedt, et al. Apoptosis resistance downstream of eIF4E: posttranscriptional activation of an anti-apoptotic transcript carrying a consensus hairpin structure Nucleic Acids Res., September 11, 2006; 34(16): 4375 - 4386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tanii, Y. Yonemitsu, T. Fujii, Y. Shikada, R.-i. Kohno, M. Onimaru, S. Okano, M. Inoue, M. Hasegawa, T. Onohara, et al. Diabetic Microangiopathy in Ischemic Limb Is a Disease of Disturbance of the Platelet-Derived Growth Factor-BB/Protein Kinase C Axis but Not of Impaired Expression of Angiogenic Factors Circ. Res., January 6, 2006; 98(1): 55 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. F. Costa, M. Balcells, E. R. Edelman, L. M. Nadler, and A. A. Cardoso Proangiogenic stimulation of bone marrow endothelium engages mTOR and is inhibited by simultaneous blockade of mTOR and NF-{kappa}B Blood, January 1, 2006; 107(1): 285 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Shen, S. P. Halenda, M. Sturek, and P. A. Wilden Cell-Signaling Evidence for Adenosine Stimulation of Coronary Smooth Muscle Proliferation via the A1 Adenosine Receptor Circ. Res., September 16, 2005; 97(6): 574 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Md. R. Abid, K. Yano, S. Guo, V. I. Patel, G. Shrikhande, K. C. Spokes, C. Ferran, and W. C. Aird Forkhead Transcription Factors Inhibit Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia J. Biol. Chem., August 19, 2005; 280(33): 29864 - 29873. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Rosner, N. McCarthy, and M. Bennett Rapamycin inhibits human in stent restenosis vascular smooth muscle cells independently of pRB phosphorylation and p53 Cardiovasc Res, June 1, 2005; 66(3): 601 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fasciano, R. C. Patel, I. Handy, and C. V. Patel Regulation of Vascular Smooth Muscle Proliferation by Heparin: INHIBITION OF CYCLIN-DEPENDENT KINASE 2 ACTIVITY BY p27kip1 J. Biol. Chem., April 22, 2005; 280(16): 15682 - 15689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Gabele, S. Reif, S. Tsukada, R. Bataller, Y. Yata, T. Morris, L. W. Schrum, D. A. Brenner, and R. A. Rippe The Role of p70S6K in Hepatic Stellate Cell Collagen Gene Expression and Cell Proliferation J. Biol. Chem., April 8, 2005; 280(14): 13374 - 13382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Sedding, J. Hermsen, U. Seay, O. Eickelberg, W. Kummer, C. Schwencke, R. H. Strasser, H. Tillmanns, and R. C. Braun-Dullaeus Caveolin-1 Facilitates Mechanosensitive Protein Kinase B (Akt) Signaling In Vitro and In Vivo Circ. Res., April 1, 2005; 96(6): 635 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Li and B. E. Sumpio Strain-induced vascular endothelial cell proliferation requires PI3K-dependent mTOR-4E-BP1 signal pathway Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1591 - H1597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. V. Gerasimovskaya, D. A. Tucker, and K. R. Stenmark Activation of phosphatidylinositol 3-kinase, Akt, and mammalian target of rapamycin is necessary for hypoxia-induced pulmonary artery adventitial fibroblast proliferation J Appl Physiol, February 1, 2005; 98(2): 722 - 731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. V. Gerasimovskaya, D. A. Tucker, M. Weiser-Evans, J. M. Wenzlau, D. J. Klemm, M. Banks, and K. R. Stenmark Extracellular ATP-induced Proliferation of Adventitial Fibroblasts Requires Phosphoinositide 3-Kinase, Akt, Mammalian Target of Rapamycin, and p70 S6 Kinase Signaling Pathways J. Biol. Chem., January 21, 2005; 280(3): 1838 - 1848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J Carter, M. Aggarwal, G. A Kopia, F. Tio, P. S Tsao, R. Kolata, A. C Yeung, G. Llanos, J. Dooley, and R. Falotico Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model Cardiovasc Res, September 1, 2004; 63(4): 617 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Andres Control of vascular cell proliferation and migration by cyclin-dependent kinase signalling: new perspectives and therapeutic potential Cardiovasc Res, July 1, 2004; 63(1): 11 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Mourani, P. J. Garl, J. M. Wenzlau, T. C. Carpenter, K. R. Stenmark, and M. C.M. Weiser-Evans Unique, Highly Proliferative Growth Phenotype Expressed by Embryonic and Neointimal Smooth Muscle Cells Is Driven by Constitutive Akt, mTOR, and p70S6K Signaling and Is Actively Repressed by PTEN Circulation, March 16, 2004; 109(10): 1299 - 1306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zhou, J. Li, A. M. Goldsmith, D. C. Newcomb, D. M. Giannola, R. G. Vosk, E. M. Eves, M. R. Rosner, J. Solway, and M. B. Hershenson Human Bronchial Smooth Muscle Cell Lines Show a Hypertrophic Phenotype Typical of Severe Asthma Am. J. Respir. Crit. Care Med., March 15, 2004; 169(6): 703 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Martin, E. M. Rzucidlo, B. L. Merenick, D. C. Fingar, D. J. Brown, R. J. Wagner, and R. J. Powell The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation Am J Physiol Cell Physiol, March 1, 2004; 286(3): C507 - C517. [Abstract] [Full Text]
|
|
|
|
|
|
P. Deleris, D. Bacqueville, S. Gayral, L. Carrez, J.-P. Salles, B. Perret, and M. Breton-Douillon SHIP-2 and PTEN Are Expressed and Active in Vascular Smooth Muscle Cell Nuclei, but Only SHIP-2 Is Associated with Nuclear Speckles J. Biol. Chem., October 3, 2003; 278(40): 38884 - 38891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. Shin, H. J. Lee, M. Nishida, M.-S. Lee, R. Tamura, S. Yamashita, Y. Matsuzawa, I.-K. Lee, and G. Y. Koh Betacellulin and Amphiregulin Induce Upregulation of Cyclin D1 and DNA Synthesis Activity Through Differential Signaling Pathways in Vascular Smooth Muscle Cells Circ. Res., August 22, 2003; 93(4): 302 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Sedding, U. Seay, L. Fink, M. Heil, W. Kummer, H. Tillmanns, and R. C. Braun-Dullaeus Mechanosensitive p27Kip1 Regulation and Cell Cycle Entry in Vascular Smooth Muscle Cells Circulation, August 5, 2003; 108(5): 616 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Dugourd, M. Gervais, P. Corvol, and C. Monnot Akt Is a Major Downstream Target of PI3-Kinase Involved in Angiotensin II-Induced Proliferation Hypertension, April 1, 2003; 41(4): 882 - 890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Diez-Juan and V. Andres Coordinate Control of Proliferation and Migration by the p27Kip1/Cyclin-Dependent Kinase/Retinoblastoma Pathway in Vascular Smooth Muscle Cells and Fibroblasts Circ. Res., March 7, 2003; 92(4): 402 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Ferreira, A. A. Peter, T. A. Salerno, H. Bolooki, and E. de Marchena Clinical impact of drug-eluting stents in changing referral practices for coronary surgical revascularization in a tertiary care center Ann. Thorac. Surg., February 1, 2003; 75(2): 485 - 489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R Bennett IN-STENT STENOSIS: PATHOLOGY AND IMPLICATIONS FOR THE DEVELOPMENT OF DRUG ELUTING STENTS Heart, February 1, 2003; 89(2): 218 - 224. [Full Text] [PDF]
|
|
|
|
|
|
M. Karbowniczek, J. Yu, and E. P. Henske Renal Angiomyolipomas from Patients with Sporadic Lymphangiomyomatosis Contain Both Neoplastic and Non-Neoplastic Vascular Structures Am. J. Pathol., February 1, 2003; 162(2): 491 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. D. Li, E. R. Block, and J. M. Patel Activation of multiple signaling modules is critical in angiotensin IV-induced lung endothelial cell proliferation Am J Physiol Lung Cell Mol Physiol, October 1, 2002; 283(4): L707 - L716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Goncharova, A. J. Ammit, C. Irani, R. G. Carroll, A. J. Eszterhas, R. A. Panettieri, and V. P. Krymskaya PI3K is required for proliferation and migration of human pulmonary vascular smooth muscle cells Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L354 - L363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Huang and C. D. Kontos Inhibition of Vascular Smooth Muscle Cell Proliferation, Migration, and Survival by the Tumor Suppressor Protein PTEN Arterioscler Thromb Vasc Biol, May 1, 2002; 22(5): 745 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Beyar and A. Roguin The sirolimus coated stent: will the Achilles heel of interventional cardiology finally be cured? Eur. Heart J., November 2, 2001; 22(22): 2054 - 2057. [PDF]
|
|